Latest PEG ratio for AstraZeneca PLC: 45.19 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow45.19
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for AZNCF is 45.19. That is above the Healthcare sector average of 2.89. Investors often review this figure alongside AstraZeneca PLC's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, AZNCF currently prints 45.19 for PEG ratio, while the sector average sits near 2.89. That is roughly 1463.2% above the sector mean. Large gaps often invite a closer look at AstraZeneca PLC's growth, margins, and balance sheet.
A PEG ratio of 45.19 for AstraZeneca PLC is not 'good' or 'bad' on its own. Compare it with the peer average (2.89) and with AZNCF's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting AZNCF's PEG ratio (45.19), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack AstraZeneca PLC's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.